|1.||Palmenberg, Ann C: 3 articles (10/2015 - 09/2005)|
|2.||Ciomperlik, Jessica J: 1 article (10/2015)|
|3.||Basta, Holly A: 1 article (10/2015)|
|4.||Ganem, D: 1 article (05/2010)|
|5.||Chen, E C: 1 article (05/2010)|
|6.||Chiu, C Y: 1 article (05/2010)|
|7.||Greninger, A L: 1 article (05/2010)|
|8.||Parsonnet, J: 1 article (05/2010)|
|9.||Haggerty, T D: 1 article (05/2010)|
|10.||Delwart, E: 1 article (05/2010)|
|1.||Nuclear Pore Complex Proteins (Nucleoporins)IBA
03/01/2006 - "As evidenced by electron microscopy, cardiovirus infection resulted in alteration of the nuclear pores, but it did not trigger degradation of the nucleoporins known to be degraded in the poliovirus-infected cells. "
10/01/2015 - "Cardiovirus infections inhibit nucleocytoplasmic trafficking by Leader protein-induced phosphorylation of Phe/Gly-containing nucleoporins (Nups). "
05/01/2010 - "adults carry antibodies to the genotype 2 cardioviruses, of which 80% generate neutralizing antibodies, in agreement with previous data showing that cardiovirus infection is widespread in humans. "
07/20/1999 - "Cardiovirus infections in mice produce similar anti-VIA antibodies, and in view of recently developed attenuated Mengo vaccines and live Mengo vectors, these VIA responses are also under investigation as potential correlates of vaccine efficacy. "
|4.||Eukaryotic Initiation Factor-4G (Eukaryotic Initiation Factor 4G)IBA
|5.||Guanidine (Guanidine Nitrate)FDA Link